Jun Qian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jun Qian has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Chang Diao
Department of General Surgery, The First Affiliated Hospital of Kunming Medical University
2 shared publications - Ruochuan Cheng
Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China
2 shared publications - Yunhai Ma
The First Affiliated Hospital of Kunming Medical University, Department of Thyroid Surgery, Kunming, China
2 shared publications B. Zhang
Department of Pulmonary, Shanghai Chest Hospital, Shanghai, China
1 shared publication- Baohui Han
Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Frank Qian
Section of Cardiovascular Medicine, Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA
1 shared publication
Latest Publications
- Open Access
- 6 February 2022
- Published by Elsevier in Jornal de Pediatria
- Vol. 98 (4) , 425-430
Surgical treatment of pediatric and adolescent papillary thyroid cancer: a retrospective study of 54 patients in a single center
- 6 February 2022
- Published by Elsevier in Jornal de Pediatria
- Vol. 98 (4) , 425-430
Open AccessSurgical treatment of pediatric and adolescent papillary thyroid cancer: a retrospective study of 54 patients in a single center
- Open Access
- 1 December 2021
- Published by China Science Publishing & Media Ltd. in Journal of Zhejiang University (Medical Sciences)
- Vol. 50 (6) , 722-729
Risk probability model for residual metastatic lymph node in patients with papillary thyroid microcarcinoma undergoing cervical central lymph node dissection
通过大样本甲状腺微小乳头状癌(PTMC)队列建立概率模型,量化颈部中央淋巴结(简称中央淋巴结)清扫术后残余转移性淋巴结风险。 回顾性分析2007—2020年昆明医科大学第一附属医院甲状腺疾病诊治中心诊断为PTMC、由高手术量医生执行甲状腺切除+中央淋巴结清扫且至少检测1枚淋巴结的病例,进一步描述阳性淋巴结的分布特征并建立评价隐匿性转移性淋巴结风险的数学模型。使用β-二项分布估计隐匿性转移性中央淋巴结的概率作为淋巴结清扫(检测)数的函数。 概率模型共纳入5399例连续病例,观察到转移性中央淋巴结1664例(30.8%)。经过模型校正,真实淋巴结转移率由30.8%升高至38.9%。在清扫(检测)1枚淋巴结时,中央淋巴结假阴性的概率为31.3%,而当清扫(检测)7枚和12枚淋巴结时,假阴性的概率分别降低至10.0%和4.9%。合并桥本甲状腺炎病例的概率模型敏感性分析与主分析显示基本一致的稳健结果。 本研究量化了PTMC患者中央淋巴结清扫术后的隐匿性残余转移性淋巴结风险,可以作为评估术后复发/残余风险的补充指标,也为通过回顾性数据资料评估残余转移性淋巴结对肿瘤患者预后的影响提供新的方法。
- 1 December 2021
- Published by China Science Publishing & Media Ltd. in Journal of Zhejiang University (Medical Sciences)
- Vol. 50 (6) , 722-729
Open AccessRisk probability model for residual metastatic lymph node in patients with papillary thyroid microcarcinoma undergoing cervical central lymph node dissection
通过大样本甲状腺微小乳头状癌(PTMC)队列建立概率模型,量化颈部中央淋巴结(简称中央淋巴结)清扫术后残余转移性淋巴结风险。 回顾性分析2007—2020年昆明医科大学第一附属医院甲状腺疾病诊治中心诊断为PTMC、由高手术量医生执行甲状腺切除+中央淋巴结清扫且至少检测1枚淋巴结的病例,进一步描述阳性淋巴结的分布特征并建立评价隐匿性转移性淋巴结风险的数学模型。使用β-二项分布估计隐匿性转移性中央淋巴结的概率作为淋巴结清扫(检测)数的函数。 概率模型共纳入5399例连续病例,观察到转移性中央淋巴结1664例(30.8%)。经过模型校正,真实淋巴结转移率由30.8%升高至38.9%。在清扫(检测)1枚淋巴结时,中央淋巴结假阴性的概率为31.3%,而当清扫(检测)7枚和12枚淋巴结时,假阴性的概率分别降低至10.0%和4.9%。合并桥本甲状腺炎病例的概率模型敏感性分析与主分析显示基本一致的稳健结果。 本研究量化了PTMC患者中央淋巴结清扫术后的隐匿性残余转移性淋巴结风险,可以作为评估术后复发/残余风险的补充指标,也为通过回顾性数据资料评估残余转移性淋巴结对肿瘤患者预后的影响提供新的方法。
- 1 April 2018
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 13 (4) , S82
140PD Complex epidermal growth factor receptor (EGFR) mutations and responses to tyrosine kinase inhibitors (TKIs) in advanced lung adenocarcinomas
- 1 April 2018
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 13 (4) , S82
140PD Complex epidermal growth factor receptor (EGFR) mutations and responses to tyrosine kinase inhibitors (TKIs) in advanced lung adenocarcinomas